Funding
← Back to your selection

Vida Ventures

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Jul 20, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$212M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
InduPro

Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease

$77MSeries B
Role not disclosed